A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and ...
Acanthamoeba keratitis is a rare but blinding parasitic eye disease. Experts share how to avoid it and treat it.
An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 ...
The persistent corneal edema market is experiencing steady growth, driven by rising clinical awareness, improved postoperative monitoring, and growing focus on endothelial dysfunction-related ...
Thiruvananthapuram General Hospital has created history by successfully performing a corneal transplant surgery, the first of its kind to be conducted at a district-level hospital in India. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results